Healthy adults
Conditions
Interventions
Participants will intake placebo (200 mL) within 15 minutes
Participants will intake test liquid 1(200 mL) within 15 minutes
Participants will intake test liquid 2(200 mL) within 15 minutes
Participan
Sponsors
DeNA Life Science, Inc
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy men and women, aged 20-59 years, at the time of an informed consent 2) Subjects who have given written consent to participate in research conducted by DeNA Life Science using samples and information obtained through MYCODE, the genetic testing service 3) Subjects that are given sufficient explanation about the purpose and contents of the study, and those agreed and volunteered to participate with good understanding of the study 4) Subjects who are able to come to the designated study date and participate in the study 5) Subjects with BMI less than 30.0 6) Non-smokers (those that have not smoked in the past year)
Exclusion criteria
Exclusion criteria: 1) Subjects who are receiving continuous pharmaceutical treatment 2) Subjects with previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive system) 3) Subjects who have hay fever (during the study period) and/or allergic rhinitis (seasonal or year-round) 4) Subjects who are receiving nutrition therapy or physical therapy under doctor's supervision 5) Subjects who are regularly taking OTC medicines, quasi-drugs, and/or any food/functional food claiming an effect on autonomic nervous system, metabolism, and sleep (except for those who will be able to quit taking these after agreeing to participate until the end of the study) 6) Subjects who drink excessively (drinking 60g of pure alcohol or more, for more than five days a week) 7) Subjects with extremely irregular life cycles (e.g., midnight shift work) and/or those with extremely irregular dining habits 8) Subjects with current or past (less than 1 month) experience of participating in other clinical studies at the time of informed consent, or those planning to participate in other clinical studies during or after (within four weeks) the study period 9) Subjects who might be under extreme stress due to large life events (e.g., changing jobs, moving, divorce) that has happened three months prior to agreeing to participate in the study 10) Subjects with difficulty not taking alcohol the day before their scheduled date of the study 11) Subjects with allergy to certain medicine and/or food 12) Subjects with defects in heart rate measurement (subjects with cardiac pacemakers or thick chest hair) 13) Subjects who cannot drink alcohol 14) Subjects who cannot drink energy drinks 15) Female subjects who are pregnant and/or lactating 16) Subjects with a severe symptom of PMS (premenstrual syndrome) 17) Any other subjects who are judged by the principal investigator responsible for the study to be inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychological evaluation Heart rate data | — |
Secondary
| Measure | Time frame |
|---|---|
| Genetic polymorphism Interoceptive sense Values and Personality survey Background survey (menstrual cycle, levels of menstrual pain, and beverage intake preferences) Beverages drinking patterns and behaviors Flavor evaluation BMI Stress Lifestyle (obesity) | — |
Countries
Japan
Contacts
Public ContactRyuichiro Kurata
DeNA Life Science, Inc MYCODE service Dept
Outcome results
None listed